
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 07:15

Facebook's algorithms 'supercharged' hate speech in Ethiopia's Tigray conflict
Rights group Amnesty International makes damning allegations against the social media giant.
2023-10-31 22:48

US labor costs growth beat expectations in third quarter
WASHINGTON U.S. labor costs increased solidly in the third quarter amid strong wage growth, the latest indication that
2023-10-31 20:51

AB Inbev Says Profit Still on Track After US Transgender Row
Anheuser-Busch InBev NV kept its annual profit forecast and announced a $1 billion share buyback, even as US
2023-10-31 16:58

Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:57

Spain Weighs Buying Telefonica Stake to Counter Saudi Deal
The Spanish government is considering buying a stake in Telefonica SA following Saudi Telecom Co.’s plan to become
2023-10-31 16:53

Daiwa Announces Share Buyback as Profit Climbs on Retail Business
Daiwa Securities Group Inc.’s profit jumped last quarter as all the main businesses fired for Japan’s second-biggest brokerage.
2023-10-31 16:53

India, Taiwan Tourists Can Enter Thailand Without Visa For Next Six Months
Thailand will waive visa for travelers from India and Taiwan for six months ahead of the year-end holiday
2023-10-31 14:55

Philippines to Protect Territory ‘At All Cost’ Amid Sea Row
The Philippines on Tuesday vowed to protect its territory “at all cost”, a day after China’s military said
2023-10-31 14:28

Japan Industrial Production Growth Misses Consensus Ahead of BOJ
Japan’s industrial production rebounded at a pace that was weaker than expected, ahead of a closely watched Bank
2023-10-31 09:54

Apple Unveils New Laptops, iMac and Trio of More Powerful Chips
Apple Inc. announced a new iMac, MacBook Pros and the third generation of its in-house Mac processor line,
2023-10-31 09:53

Brookfield Fund Loses Consultant Approval After Leaders Exit
Investment consultant Aksia LLC rescinded its approval for Brookfield Asset Management’s special-situations fund after two top executives left,
2023-10-31 09:28